Dova Pharmaceuticals Inc. Insider Trading for November 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Dova Pharmaceuticals Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Dova Pharmaceuticals Inc. for November 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 15 2019 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | J | 0.00 | 3,125,851 | 0 | 0 | 3.1 M to 0 (-100.00 %) |
| Nov 15 2019 | DOVA | Dova Pharmaceutica ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Sell | J | 0.00 | 3,125,851 | 0 | 0 | 3.1 M to 0 (-100.00 %) |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | ZACCARDELLI DAVID | President & CEO | Option Exercise | D | 6.07 | 1,000,000 | 6,070,000 | 0 | |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | ZACCARDELLI DAVID | President & CEO | Option Exercise | D | 6.07 | 1,000,000 | 6,070,000 | 0 | |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | ZACCARDELLI DAVID | President & CEO | Sell | D | 0.00 | 76,647 | 0 | 0 | 76.6 K to 0 (-100.00 %) |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | ZACCARDELLI DAVID | President & CEO | Sell | D | 0.00 | 76,647 | 0 | 0 | 76.6 K to 0 (-100.00 %) |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Wysenski Nancy | Director | Option Exercise | D | 9.36 | 10,000 | 93,600 | 0 | |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Wysenski Nancy | Director | Sell | D | 0.00 | 6,274 | 0 | 0 | 6.3 K to 0 (-100.00 %) |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Stalfort Sean | Director | Sell | U | 27.50 | 635,665 | 17,480,788 | 0 | 635.7 K to 0 (-100.00 %) |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Novak Alfred J | Director | Option Exercise | D | 9.36 | 10,000 | 93,600 | 0 | |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Novak Alfred J | Director | Option Exercise | D | 7.32 | 33,000 | 241,560 | 0 | |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Novak Alfred J | Director | Sell | D | 0.00 | 6,901 | 0 | 0 | 6.9 K to 0 (-100.00 %) |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Sell | U | 27.50 | 1,783,226 | 49,038,715 | 0 | 1.8 M to 0 (-100.00 %) |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Manning Paul B | Director | Sell | U | 27.50 | 12,979,016 | 356,922,940 | 0 | 13 M to 0 (-100.00 %) |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Laliberte Kevin | Sr. VP, Product Dev ... | Option Exercise | D | 16.08 | 10,000 | 160,800 | 0 | |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Laliberte Kevin | Sr. VP, Product Dev ... | Option Exercise | D | 8.82 | 50,000 | 441,000 | 0 | |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Laliberte Kevin | Sr. VP, Product Dev ... | Option Exercise | D | 3.73 | 24,750 | 92,318 | 0 | |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Laliberte Kevin | Sr. VP, Product Dev ... | Option Exercise | D | 3.73 | 115,500 | 430,815 | 0 | |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Laliberte Kevin | Sr. VP, Product Dev ... | Sell | D | 0.00 | 4,761 | 0 | 0 | 4.8 K to 0 (-100.00 %) |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | JEFFS ROGER | Director | Option Exercise | D | 9.36 | 10,000 | 93,600 | 0 | |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | JEFFS ROGER | Director | Option Exercise | D | 7.32 | 33,000 | 241,560 | 0 | |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | JEFFS ROGER | Director | Sell | D | 0.00 | 66,993 | 0 | 0 | 67 K to 0 (-100.00 %) |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Hoitt Jason | Chief Commercial Of ... | Option Exercise | D | 6.07 | 250,000 | 1,517,500 | 0 | |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Hoitt Jason | Chief Commercial Of ... | Sell | D | 0.00 | 9,970 | 0 | 0 | 10 K to 0 (-100.00 %) |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Goldman Steven M. | Director | Option Exercise | D | 9.36 | 8,333 | 77,997 | 0 | |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Goldman Steven M. | Director | Option Exercise | D | 7.32 | 10,083 | 73,808 | 0 | |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Goldman Steven M. | Director | Sell | D | 0.00 | 5,000 | 0 | 0 | 5 K to 0 (-100.00 %) |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | Goldman Steven M. | Director | Sell | D | 0.00 | 144,280 | 0 | 0 | 144.3 K to 0 (-100.00 %) |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | ALLEN LEE F MD PhD | Chief Medical Offic ... | Option Exercise | D | 16.08 | 10,000 | 160,800 | 0 | |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | ALLEN LEE F MD PhD | Chief Medical Offic ... | Option Exercise | D | 3.73 | 251,466 | 937,968 | 0 | |
| Nov 12 2019 | DOVA | Dova Pharmaceutica ... | ALLEN LEE F MD PhD | Chief Medical Offic ... | Sell | D | 0.00 | 9,635 | 0 | 0 | 9.6 K to 0 (-100.00 %) |